AfricaRegulatory

African Pharmaceutical Regulatory Intelligence

CLOMIPRAMINE

11 registrations across 3 African markets— 5 active

Markets with CLOMIPRAMINE

Recent registrations

Brand / ProductMarketHolderStatusExpires
ANAFRANIL
Comprime enrobé / 10 mg
🇹🇳TunisiaALFASIGMA FRANCEexpiredMar 2016
ANAFRANIL
Comprime enrobé / 25 mg
🇹🇳TunisiaALFASIGMA FRANCEexpiredMar 2016
ANAFRANIL
Solution injectable / 25 mg
🇹🇳TunisiaALFASIGMA FRANCEexpiredMar 2016
ANAFRANIL 75 MG
Comprimé pelliculé sécable / 75 MG
🇹🇳TunisiaALFASIGMA FRANCEexpiredMar 2016
CLOMIPRAMINE (CHLORHYDRATE) MYLAN
Comprimé pelliculé / 10 MG
🇹🇳TunisiaMYLAN S.A.SexpiredJan 2004
CLOMIPRAMINE (CHLRHYDRATE) VIATRIS
Comprimé pelliculé / 25 MG
🇹🇳TunisiaVIATRIS SANTEexpiredMay 2001
ANAFRANIL
ampoule injectable / 25 mg / 2ML
🇸🇳SenegalALFASIGMAactive
ANAFRANIL
COMPRIME ENROBE
🇲🇦Moroccoactive
ANAFRANIL
SOLUTION INJECTABLE
🇲🇦Moroccoactive
ANAFRANIL
COMPRIME ENROBE
🇲🇦Moroccoactive
ANAFRANIL
ampoule injectable / 25 mg / 2ML
🇸🇳SenegalALFASIGMAactive

CLOMIPRAMINE in Africa — Regulatory Overview

CLOMIPRAMINE is registered across 3 African markets with 11 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Tunisia, Morocco, Senegal. AfricaRegulatory refreshes this data daily from official government sources.

Of the 11 registrations, 5 (45%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.